In The News

In The News

61 Results found
61 Results found

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Waldencast Reports Q1 2025 Financial Results

Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast